(Q34566772)

3 August 2017

1 reference

title

Prospective investigations of the prodromal state of schizophrenia: review of studies (English)

1 reference

3 August 2017

0 references

Olsen KA

1

1 reference

3 August 2017

Rosenbaum B

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Acta Psychiatrica Scandinavica

3 August 2017

number of pages

26

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 August 2017

volume

113

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

247-272

1 reference

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The prodromal phase of first-episode psychosis: past and current conceptualizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Cognitive-behavioral therapy in the pre-psychotic phase: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Early detection and secondary prevention of psychosis: facts and visions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Cognitive functions in prepsychotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Monitoring and care of young people at incipient risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Diagnosing schizophrenia in the initial prodromal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Symptom assessment in schizophrenic prodromal states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The development, use, and reliability of the brief psychiatric rating scale (nursing modification)--an assessment procedure for the nursing team in clinical and research settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Assessing coping strategies: a theoretically based approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

EASE: Examination of Anomalous Self-Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Inventory of interpersonal problems: psychometric properties and clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The reliability of the family history method for psychiatric diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

New scales for the assessment of schizotypy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Measurement of premorbid adjustment in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Quality of life in the evaluation of community support systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Royal Park Multidiagnostic Instrument for Psychosis: Part I. Rationale and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

SCAN. Schedules for Clinical Assessment in Neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The psychopathology, neuropsychology, and neurobiology of associative and working memory in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The schizophrenia prodrome: treatment and high-risk perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Neuropsychological status of subjects at high risk for a first episode of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Prevention of schizophrenia: can it be achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The assessment of "prodromal schizophrenia": unresolved issues and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The New York high risk project to the Hillside recognition and prevention (RAP) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Early detection and intervention in first-episode schizophrenia: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Axis-I disorders and vulnerability to psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Reducing the duration of untreated first-episode psychosis: effects on clinical presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

One-year outcome in first episode psychosis patients in the Swedish Parachute project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Preventing severe mental illnesses--new prospects and ethical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Ethics and early intervention in psychosis: keeping up the pace and staying in step

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Psychosis treatment prior to psychosis onset: ethical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Treatment of the schizophrenia prodrome: is it presently ethical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Psychosis: conceptual and ethical aspects of early diagnosis and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Pharmacological intervention in the initial prodromal phase of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Treatment histories of patients with a syndrome putatively prodromal to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Overview of the First Annual Workshop on the Schizophrenia Prodrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Pseudoneurotic forms of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Scales for physical and social anhedonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Magical ideation as an indicator of schizotypy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Routine outcome assessment in mental health research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Neuropsychological and neurophysiological findings in individuals suspected to be at risk for schizophrenia: preliminary results from the Basel early detection of psychosis study - Fruherkennung von Psychosen (FEPSY)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00697.X

10.1111/J.1600-0447.2005.00697.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference